1,263 research outputs found
XNOR Neural Engine: a Hardware Accelerator IP for 21.6 fJ/op Binary Neural Network Inference
Binary Neural Networks (BNNs) are promising to deliver accuracy comparable to
conventional deep neural networks at a fraction of the cost in terms of memory
and energy. In this paper, we introduce the XNOR Neural Engine (XNE), a fully
digital configurable hardware accelerator IP for BNNs, integrated within a
microcontroller unit (MCU) equipped with an autonomous I/O subsystem and hybrid
SRAM / standard cell memory. The XNE is able to fully compute convolutional and
dense layers in autonomy or in cooperation with the core in the MCU to realize
more complex behaviors. We show post-synthesis results in 65nm and 22nm
technology for the XNE IP and post-layout results in 22nm for the full MCU
indicating that this system can drop the energy cost per binary operation to
21.6fJ per operation at 0.4V, and at the same time is flexible and performant
enough to execute state-of-the-art BNN topologies such as ResNet-34 in less
than 2.2mJ per frame at 8.9 fps.Comment: 11 pages, 8 figures, 2 tables, 3 listings. Accepted for presentation
at CODES'18 and for publication in IEEE Transactions on Computer-Aided Design
of Circuits and Systems (TCAD) as part of the ESWEEK-TCAD special issu
Personality and dissociative experiences in smartphone users
The aim of this study was to explore the relationship between Problematic Smartphone Use (PSU), dissociative experiences and some characteristics of personality. The sample consisted of 400 Italian college students aged between 20 and 24 (M = 21.59, SD = 1.43). The materials included: a questionnaire on the use of smartphones, the Smartphone Addiction Scale (SAS-SV), the Dissociative Experience Scale (DES), and the Ten Item Personality Inventory (TIPI).
Results showed that the college students in our sample used their smartphones mainly for messaging (50%), calling (42.5%), accessing the internet (38%), connecting via social networks (33.5%), taking photos (26.5%), gaming (8.5%) and using applications (.5%). According to the results of the SAS-SV, 70% of our sample showed PSU, without gender differences. Regarding the correlation with personality factors, intensive use of smartphones corresponds to lower emotional stability and the extraversion or 'energy' factor is predictive near the significance cut-off (p = .06), while among the dissociative experiences, passive influence and dissociative amnesia are the best predictors of smartphone addiction. The other variables are less significant (p = .07). The results underline the importance of detecting the PSU predictors in college students, in order to prevent psychopathological consequences
Always-On 674uW @ 4GOP/s Error Resilient Binary Neural Networks with Aggressive SRAM Voltage Scaling on a 22nm IoT End-Node
Binary Neural Networks (BNNs) have been shown to be robust to random
bit-level noise, making aggressive voltage scaling attractive as a power-saving
technique for both logic and SRAMs. In this work, we introduce the first fully
programmable IoT end-node system-on-chip (SoC) capable of executing
software-defined, hardware-accelerated BNNs at ultra-low voltage. Our SoC
exploits a hybrid memory scheme where error-vulnerable SRAMs are complemented
by reliable standard-cell memories to safely store critical data under
aggressive voltage scaling. On a prototype in 22nm FDX technology, we
demonstrate that both the logic and SRAM voltage can be dropped to 0.5Vwithout
any accuracy penalty on a BNN trained for the CIFAR-10 dataset, improving
energy efficiency by 2.2X w.r.t. nominal conditions. Furthermore, we show that
the supply voltage can be dropped to 0.42V (50% of nominal) while keeping more
than99% of the nominal accuracy (with a bit error rate ~1/1000). In this
operating point, our prototype performs 4Gop/s (15.4Inference/s on the CIFAR-10
dataset) by computing up to 13binary ops per pJ, achieving 22.8 Inference/s/mW
while keeping within a peak power envelope of 674uW - low enough to enable
always-on operation in ultra-low power smart cameras, long-lifetime
environmental sensors, and insect-sized pico-drones.Comment: Submitted to ISICAS2020 journal special issu
An IoT Endpoint System-on-Chip for Secure and Energy-Efficient Near-Sensor Analytics
Near-sensor data analytics is a promising direction for IoT endpoints, as it
minimizes energy spent on communication and reduces network load - but it also
poses security concerns, as valuable data is stored or sent over the network at
various stages of the analytics pipeline. Using encryption to protect sensitive
data at the boundary of the on-chip analytics engine is a way to address data
security issues. To cope with the combined workload of analytics and encryption
in a tight power envelope, we propose Fulmine, a System-on-Chip based on a
tightly-coupled multi-core cluster augmented with specialized blocks for
compute-intensive data processing and encryption functions, supporting software
programmability for regular computing tasks. The Fulmine SoC, fabricated in
65nm technology, consumes less than 20mW on average at 0.8V achieving an
efficiency of up to 70pJ/B in encryption, 50pJ/px in convolution, or up to
25MIPS/mW in software. As a strong argument for real-life flexible application
of our platform, we show experimental results for three secure analytics use
cases: secure autonomous aerial surveillance with a state-of-the-art deep CNN
consuming 3.16pJ per equivalent RISC op; local CNN-based face detection with
secured remote recognition in 5.74pJ/op; and seizure detection with encrypted
data collection from EEG within 12.7pJ/op.Comment: 15 pages, 12 figures, accepted for publication to the IEEE
Transactions on Circuits and Systems - I: Regular Paper
Universal newborn hearing screening in the Lazio region, Italy
Background: The introduction of Universal Newborn Hearing Screening (UNHS) programs has drastically contributed to the early diagnosis of hearing loss in children, allowing prompt intervention with significant results on speech and language development in affected children. UNHS in the Lazio region has been initially deliberated in 2012; however, the program has been performed on a universal basis only from 2015. The aim of this retrospective study is to present and discuss the preliminary results of the UNHS program in the Lazio region for the year 2016, highlighting the strengths and weaknesses of the program. Methods: Data from screening facilities in the Lazio region for year 2016 were retrospectively analyzed. Data for Level I centers were supplied by the Lazio regional offices; data for Level II and III centers were provided by units that participated to the study. Results: During 2016, a total of 44,805 babies were born in the Lazio region. First stage screening was performed on 41,821 children in 37 different birth centers, with a coverage rate of 93.3%. Of these, 38.977 (93.2%) obtained a "pass" response; children with a "refer" result in at least one ear were 2844 (6.8%). Data from Level II facilities are incomplete due to missing reporting, one of the key issues in Lazio UNHS. Third stage evaluation was performed on 365 children in the three level III centers of the region, allowing identification of 70 children with unilateral (40%) or bilateral (60%) hearing loss, with a prevalence of 1.6/1000. Conclusions: The analysis of 2016 UNHS in the Lazio region allowed identification of several strengths and weaknesses of the initial phase of the program. The strengths include a correct spread and monitoring of UNHS among Level I facilities, with an adequate coverage rate, and the proper execution of audiological monitoring and diagnosis among Level III facilities. Weakness, instead, mainly consisted in lack of an efficient and automated central process for collecting, monitoring and reporting of data and information
PCDH19 mutations in female patients from Southern Italy
AbstractPurposeMutations in PCDH19, encoding protocadherin 19 on chromosome X, cause familial epilepsy and mental retardation limited to females or Dravet-like syndrome. We wished to explore the causative role of PCDH19 gene (Xq22) in female patients with epilepsy, from Southern Italy.MethodsDirect sequencing of PCDH19 gene was conducted in 31 unrelated female patients with early onset (<1 year of age) epilepsy and a wide spectrum of phenotypes including febrile seizures, focal and generalized forms, with either sporadic or familial distribution.ResultsWe identified two de novo heterozygous novel mutations of PCDH19 gene (p.Arg550Pro, Ile508ProfsX59) in two of 31 unrelated female patients. We also identified a novel silent mutation p.Ser856=.ConclusionsThe present findings confirm that PCDH19 is a major causative gene for infantile onset familial or sporadic epilepsy in female patients with or without mental retardation
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease
Hyperkalemia may cause life-threatening cardiac and neuromuscular alterations, and it is associated with high mortality rates. Its treatment includes a multifaceted approach, guided by potassium levels and clinical presentation. In general, treatment of hyperkalemia may be directed towards stabilizing cell membrane potential, promoting transcellular potassium shift and lowering total K+ body content. The latter can be obtained by dialysis, or by increasing potassium elimination by urine or the gastrointestinal tract. Until recently, the only therapeutic option for increasing fecal K+ excretion was represented by the cation-exchanging resin sodium polystyrene sulfonate. However, despite its common use, the efficacy of this drug has been poorly studied in controlled studies, and concerns about its safety have been reported. Interestingly, new drugs, namely patiromer and sodium zirconium cyclosilicate, have been developed to treat hyperkalemia by increasing gastrointestinal potassium elimination. These medications have proved their efficacy and safety in large clinical trials, involving subjects at high risk of hyperkalemia, such as patients with heart failure and chronic kidney disease. In this review, we discuss the mechanisms of action and the updated data of patiromer and sodium zirconium cyclosilicate, considering that the availability of these new treatment options offers the possibility of improving the management of both acute and chronic hyperkalemia
- …